The cannabinoid 1 receptor (CNR1) 1359 G/A polymorphism modulates susceptibility to ulcerative colitis and the phenotype in Crohn's disease.
<h4>Background</h4>Recent evidence suggests a crucial role of the endocannabinoid system, including the cannabinoid 1 receptor (CNR1), in intestinal inflammation. We therefore investigated the influence of the CNR1 1359 G/A (p.Thr453Thr; rs1049353) single nucleotide polymorphism (SNP) on...
Enregistré dans:
Auteurs principaux: | Martin Storr, Dominik Emmerdinger, Julia Diegelmann, Simone Pfennig, Thomas Ochsenkühn, Burkhard Göke, Peter Lohse, Stephan Brand |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2010
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/da13048bf34d4a2d8f8e486e7f896ad6 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
Acta N°1359
par: Banco Central de Chile
Publié: (2021) -
Intestinal DMBT1 expression is modulated by Crohn's disease-associated IL23R variants and by a DMBT1 variant which influences binding of the transcription factors CREB1 and ATF-2.
par: Julia Diegelmann, et autres
Publié: (2013) -
Selected Morphotic Parameters Differentiating Ulcerative Colitis from Crohn’s Disease
par: Kasperczuk Anna
Publié: (2021) -
Selective biologics for ulcerative colitis and Crohn's disease – clinical utility of vedolizumab
par: Petkau JM, et autres
Publié: (2016) -
Systems biology approach highlights mechanistic differences between Crohn’s disease and ulcerative colitis
par: Pedro A. Ruiz Castro, et autres
Publié: (2021)